Nicholas J. Diamond, JD, LLM, MBe is an advisor and legal academic. He is an expert on the intersection of economic issues (especially foreign investment), human rights (especially health), and the law. His experience spans U.S. and global health policy, public health law, public international law, business and human rights, and ethics.
He is a Director and leads the Global Health Practice at C&M International, the global policy and regulatory affairs affiliate of Crowell & Moring LLP, in the Washington, D.C., office. His clients include both U.S. and international health sector stakeholders, with a particular emphasis on multinational biopharmaceutical companies. Prior to joining C&M International, he worked as a consultant for a leading advisory firm in the U.S., where he counseled multinational biopharmaceutical companies, advocacy and trade organizations, and other health sector stakeholders. Earlier in his career, he led global market strategy for the health sector at a privately owned enterprise software company with a $1B+ valuation, as well as served in advisory roles to the U.S. government, including during implementation of landmark healthcare reform legislation.
His writing has been published in law reviews, peer-reviewed journals, and major media outlets. His writing has also been discussed or featured in major media outlets (e.g., The Washington Post, Slate, Forbes). He has given invited talks in various academic and industry fora, as well as frequently appeared on U.S. news programs (e.g., Bloomberg, MSNBC) as a commentator.
He also serves as an adjunct professor of law at the Georgetown University Law Center and as an associate scholar in the Center for Global Health at the University of Pennsylvania. He has previously taught at The George Washington University and Drexel University, as well as served as an adjunct fellow in the University of Pennsylvania’s Center for Public Health Initiatives.
He holds related affiliations as a member of the Executive Committee of the Framework Convention on Global Health Alliance (a Geneva-based NGO), an assistant editor of Wolters Kluwer’s Kluwer Arbitration Blog, and a contributor to Oxford University Press’ Investment Claims.
Since 2018, he has been a PhD candidate in public international law at Leiden Law School in The Hague. He trained and qualified as a lawyer in the US, and holds graduate degrees in global health law and bioethics.
He is a Director and leads the Global Health Practice at C&M International, the global policy and regulatory affairs affiliate of Crowell & Moring LLP, in the Washington, D.C., office. His clients include both U.S. and international health sector stakeholders, with a particular emphasis on multinational biopharmaceutical companies. Prior to joining C&M International, he worked as a consultant for a leading advisory firm in the U.S., where he counseled multinational biopharmaceutical companies, advocacy and trade organizations, and other health sector stakeholders. Earlier in his career, he led global market strategy for the health sector at a privately owned enterprise software company with a $1B+ valuation, as well as served in advisory roles to the U.S. government, including during implementation of landmark healthcare reform legislation.
His writing has been published in law reviews, peer-reviewed journals, and major media outlets. His writing has also been discussed or featured in major media outlets (e.g., The Washington Post, Slate, Forbes). He has given invited talks in various academic and industry fora, as well as frequently appeared on U.S. news programs (e.g., Bloomberg, MSNBC) as a commentator.
He also serves as an adjunct professor of law at the Georgetown University Law Center and as an associate scholar in the Center for Global Health at the University of Pennsylvania. He has previously taught at The George Washington University and Drexel University, as well as served as an adjunct fellow in the University of Pennsylvania’s Center for Public Health Initiatives.
He holds related affiliations as a member of the Executive Committee of the Framework Convention on Global Health Alliance (a Geneva-based NGO), an assistant editor of Wolters Kluwer’s Kluwer Arbitration Blog, and a contributor to Oxford University Press’ Investment Claims.
Since 2018, he has been a PhD candidate in public international law at Leiden Law School in The Hague. He trained and qualified as a lawyer in the US, and holds graduate degrees in global health law and bioethics.